Process Patent Protection: Characterizing Synthetic Pathways by Stable-Isotopic Measurements - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Process Patent Protection: Characterizing Synthetic Pathways by Stable-Isotopic Measurements
The authors describe the methods by which precise analyses of stable-isotopic abundances can be used in security and forensic applications for pharmaceutical materials. These methods include product and process authentication of raw materials, pharmaceutical intermediates, drug substances, formulated drug products, and synthetic pathways. Collectively, these methods can be used to investigate and mitigate patent infringement. In the future, more complete examples will be presented containing full isotopic..

Pharmaceutical Technology

8. P.E. Sauer et al., "Compound-Specific D/H Ratios of Lipid Biomarkers from Sediments as a Proxy for Environmental and Climatic Conditions," Geochim. Comsochim. Acta 65 (2), 213–222 (2001).

9. Y. Chikaraishi and H. Naraoka, "Compound-Specific δD-δ13 C Analyses of n-Alkanes Extracted from Terrestrial and Aquatic Plants," Phytochem. 63, 361–371 (2003).

10. J.M. Hayes, "An Introduction to Isotopic Calculations," (National Ocean Sciences Accelerator Mass Spectrometry Facility, Woods Hole, MA, 2004), http://, accessed Jan. 22, 2007.

11. J.P. Jasper, "The Increasing Use of Stable Isotopes in the Pharmaceutical Industry," Pharm. Technol. 23 (10), 106–114 (1999).

12. J.M. Hayes, "Practice and Principles of Isotopic Measurements in Organic Geochemistry," (National Ocean Sciences Accelerator Mass Spectrometry Facility, Woods Hole, MA, 2002),, accessed Jan. 22, 2007.

13. J.P. Jasper, "Quantitative Estimates of Precision for Molecular Isotopic Measurements," Rap. Comm. Mass Spec., 15, 1554–1557 (2001).

14. K.M. Scott et al., "Optimal Methods for Estimating Kinetic Isotope Effects from Different Forms of the Rayleigh Distillation Equation," Geochim. Cosmochim. Acta, 68 (3), 433–442 (2004).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here